Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin

Helicobacter

Volumn 2, Issue 4, 1997, Pages 185-187

  Tompkins, David Stewart ^a   Perkin, Jill ^a   Smith, Carole ^a  

^a Leeds Public Health Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECT; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; MULTICENTER STUDY; STOMACH ANTRUM; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PYLORIC ANTRUM; TREATMENT OUTCOME;

EID: 0031310378     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1997.tb00085.x     Document Type: Article

References (14)

1. Goddard AF, Logan RPH. Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemo ther 1996;37:639-43.
2. van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996; 1:6-19.
3. Xia H, Buckley M, Keane CT, O'Morain CA. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro, J Antimicrob Chemother 1996;37: 473-81.
4. Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre-and post-treatment resistance of Helicobacter pylori strains: a key factor of treatment failure (abstract). Gut 1995;37(Suppl. 1):A55.
5. Taylor NS, Fox JG, Akopyants NS, Berg DE, Thompson N, Shames B, Yan L, Fontham E, Janney F, Hunter FM, Correa P. Long term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J Clin Microbiol 1995;33:918-23.
6. Smith C, Perkin J, Tompkins D. Comparison of E-test and disc diffusion for detection of antibiotic resistance in Helicobacter pylori. PHLS Microbiol Dig 1997;14:21-3.
7. Tompkins DS. Microbiological tests. In: Northfield TC, Mendall M, Goggin PM (editors). Helicobacter pylori infection. Dordrecht; Kluwer Academic Publishers, 1993:116-26.
8. Utrup LJ, Tanaka SK, Olson CA, Graham DY. Clarithromycin susceptibility testing breakpoints for Helicobacter pylori (abstract). Gut 1996;39 (Suppl. 2):A11-2.
9. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vanderbroucke-Grauls CMJE. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996;142:37-42.
10. Stone GG, Shortridge D, Flamm RK, Beyer J, Stamler D, Tanaka SK. PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin. Epidemiol Infect 1997; 118:119-24.
11. Schütze K, Hentschel E, Hirschl AM. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. Eur J Gastroenterol Hepatol 1996;8:41-6.
12. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, Zulawinski L, Tanaka SK. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996;1:227-8.
13. Rautelin H, Tee W, Seppala K, Kosunen TU. Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol 1994;32:1079-82.
14. Ghoneim TA, Crabtree JE, Ghoneim AT. Molecular fingerprinting of pre-and post-treatment isolates of H. pylori using the random amplified polymorphic DNA (RAPD) technique (abstract). Gut 1996;39(Suppl. 2):A81.